Sujit Kumar Debnath

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 9

Top Venues

PloS one

Expert opinion on emerging drugs

Expert opinion on drug delivery

Expert review of anti-infective therapy

Indian Institute of Technology Bombay

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Indian Institute of Technology Bombay Feb 04 2020

India

Post Doctoral Fellow :: Department of Biosciences and bioengineering

Indian Institute of Technology Bombay Aug 27 2018 - Feb 03 2020

India

Research associate :: Biosciences and Bioengineering

P. G. Institute of Medical Sciences Jul 22 2017 - Aug 25 2018

India

Assistant Professor :: Department of Pharmacy

Bengal College of Pharmaceutical Science and Research May 04 2016 - Jul 20 2017

India

Assistant Professor :: Pharmacy

N. R. Vekaria Institute of Pharmacy Oct 02 2008 - Apr 25 2016

India

Assistant Professor :: Pharmacy

Publications

Vinay Saini, Sujit Kumar Debnath, Priyanka Maske, Vikas Dighe, Rohit Srivastava
Targeted delivery of ursolic acid and oleanolic acid to lungs in the form of an inhaler for the management of tuberculosis: Pharmacokinetic and toxicity assessment. PloS one 17 (12) (2022)
Vinay Saini, Sujit Kumar Debnath, Priyanka Maske, Vikas Dighe, Rohit Srivastava
Targeted delivery of ursolic acid and oleanolic acid to lungs in the form of an inhaler for the management of tuberculosis: Pharmacokinetic and toxicity assessment. PloS one 17 (12) (2022)
Vinay Saini, Sujit Kumar Debnath, Priyanka Maske, Vikas Dighe, Rohit Srivastava
Targeted delivery of ursolic acid and oleanolic acid to lungs in the form of an inhaler for the management of tuberculosis: Pharmacokinetic and toxicity assessment. PloS one 17 (12) (2022)
Vinay Saini, Sujit Kumar Debnath, Priyanka Maske, Vikas Dighe, Rohit Srivastava
Targeted delivery of ursolic acid and oleanolic acid to lungs in the form of an inhaler for the management of tuberculosis: Pharmacokinetic and toxicity assessment. PloS one 17 (12) (2022)
Vinay Saini, Sujit Kumar Debnath, Priyanka Maske, Vikas Dighe, Rohit Srivastava
Targeted delivery of ursolic acid and oleanolic acid to lungs in the form of an inhaler for the management of tuberculosis: Pharmacokinetic and toxicity assessment. PloS one 17 (12) (2022)
Sujit Kumar Debnath, Monalisha Debnath, Rohit Srivastava, Abdelwahab Omri
Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability. Expert review of anti-infective therapy 20 (9) (2022)
Sujit Kumar Debnath, Monalisha Debnath, Rohit Srivastava, Abdelwahab Omri
Intervention of 3D printing in health care: transformation for sustainable development. Expert opinion on drug delivery 18 (11) (2021)
Pallavi Kiran, Sujit Kumar Debnath, Suditi Neekhra, Vaishali Pawar, Amreen Khan, Faith Dias, Shubham Pallod, Rohit Srivastava
Designing nanoformulation for the nose-to-brain delivery in Parkinson's disease: Advancements and barrier. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology (2021)
Sujit Kumar Debnath, Rohit Srivastava, Abdelwahab Omri
Emerging therapeutics for the management of COVID 19. Expert opinion on emerging drugs 25 (3) (2020)

Sujit Kumar Debnath.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sujit Kumar Debnath